SALT LAKE CITY, April 27, 2011 /PRNewswire/ -- Paradigm Medical
Industries, Inc. (OTC: PDMI.PK) announced its success at the annual
meeting of Vision Source, an optometric organization, which was
held at the Houston Convention
Center in Houston, Texas from
April 14-17, 2011. Over 2,300
private practice optometrists from many of the most highly regarded
practices in the United States
were in attendance at the annual meeting. The meeting
provided opportunities for participating optometrists to attend
practice building seminars, benefit from shared peer experience,
and purchase equipment from vendors approved by Vision Source.
"This important annual meeting with Vision Source's members
resulted in creating many new sales opportunities for Paradigm's
products, including the Blood Flow Analyzer™, the P60 UBM
Ultrasound Biomicroscope, the new LD 500 autoperimeter, and the new
Paramax™. New sales were made and numerous quality leads that
will lead to future sales made the meeting a great success," said
Stephen L. Davis, Paradigm's
President and Chief Executive Officer.
Mr. Davis added, "The opportunity to attend the meeting filled
an important sales objective for Paradigm to reestablish its
working relationship with the Vision Source group and introduce
Paradigm's high technology diagnostic eye care instruments for
early detection of glaucoma and other eye disorders to this
important professional eye care group."
Vision Source is an invitation only, private optometric
organization that requires its members to pay an annual membership
fee to belong and benefit from its membership. Members learn
new practice building skills, improve staff development, and gain
valuable general business tips. Members also enjoy reduced
pricing from approved vendors who financially support these
efforts.
About Paradigm Medical Industries, Inc.
Paradigm Medical Industries, Inc. is a medical device company
that develops, manufactures and distributes ophthalmic diagnostic
instruments and related products for early detection of glaucoma
and other eye disorders. The Company's primary objective is to
capture a niche market within the glaucoma and ultrasound
microscopy fields. The Company markets its products to
ophthalmologists, optometrists, universities, and clinics
throughout the United States and
internationally.
This press release contains statements that, if not verifiable
historic fact, may be viewed as forward-looking statements that
could predict future events and outcomes with respect to Paradigm
and its business. The predictions embodied in these statements will
involve risk and uncertainties and, accordingly, actual results may
differ significantly from the results discussed or implied in such
forward-looking statements.
Contact: Stephen L. Davis
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com
SOURCE Paradigm Medical Industries, Inc.